This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Available treatments for hepatitis C virus cost-effective when initiated early

March 16th, 2015

New treatments for hepatitis C virus (HCV) may be highly effective but are associated with substantial costs that may compel clinicians and patients to consider delaying treatment. However, a new study shows that immediate treatment of HCV-infected patients with moderate or advanced liver scarring is cost-effective. Immediate treatment of patients with minimal or no scarring can be cost-effective as well, particularly when lower treatment costs are assumed.

"The devastating effects of hepatitis C continue to threaten the health of many Americans, with baby boomers at particular risk. This analysis of treatment available for hepatitis C describes specific scenarios when immediate or earlier treatment can be both cost-effective and increase quality of life," said Dr. John Ward, co-author of the Hepatology study and director of CDC's Division of Viral Hepatitis.

More information:
DOI: 10.1002/hep.27736

Provided by Wiley

Citation: Available treatments for hepatitis C virus cost-effective when initiated early (2015, March 16) retrieved 25 April 2024 from https://sciencex.com/wire-news/187980639/available-treatments-for-hepatitis-c-virus-cost-effective-when-i.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.